Therapeutic modulators of STAT signalling for human diseases.

Therapeutic modulators of STAT signalling for human diseases.
复制标题

DOI:
10.1038/nrd4088
复制
发表时间:
2013-08
期刊:
Nature reviews. Drug discovery
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

信号转导和转录激活子(STAT)蛋白在生物过程中具有重要作用。STAT信号通路的异常激活也与许多人类疾病有关,包括癌症、自身免疫性疾病、类风湿性关节炎、哮喘和糖尿病。自从报道了第一个STAT蛋白的抑制剂以来,已经过去了十多年,随着治疗的继续,人们努力发现STAT信号的调节器。这篇综述讨论了针对STAT蛋白的正在进行的药物发现研究的结果,为加速发现候选药物提供了新的方向,并突出了已进入临床试验的值得注意的候选疗法。
The signal transducer and activator of transcription (STAT) proteins have important roles in biological processes. The abnormal activation of STAT signalling pathways is also implicated in many human diseases, including cancer, autoimmune diseases, rheumatoid arthritis, asthma and diabetes. Over a decade has passed since the first inhibitor of a STAT protein was reported and efforts to discover modulators of STAT signalling as therapeutics continue. This Review discusses the outcomes of the ongoing drug discovery research endeavours against STAT proteins, provides perspectives on new directions for accelerating the discovery of drug candidates, and highlights the noteworthy candidate therapeutics that have progressed to clinical trials.
DOI: 10.1016/j.ejmech.2013.01.023
发表时间: 2013-04
影响因子: 6.7
作者:
Chen, Haijun;Yang, Zhengduo;Ding, Chunyong;Chu, Lili;Zhang, Yusong;Terry, Kristin;Liu, Huiling;Shen, Qiang;Zhou, Jia
通讯作者: Zhou, Jia
DOI: 10.1165/rcmb.2008-0163oc
发表时间: 2009-11-01
影响因子: 6.4
作者:
Chiba, Yoshihiko;Todoroki, Michiko;Misawa, Miwa
通讯作者: Misawa, Miwa
DOI: 10.1089/nat.2013.0422
发表时间: 2013-06-01
影响因子: 4
作者:
Burel, Sebastien A.;Han, So-Ri;Henry, Scott P.
通讯作者: Henry, Scott P.
DOI: 10.1182/blood-2002-03-0740
发表时间: 2003-01-01
期刊: BLOOD
影响因子: 20.3
作者:
Buitenhuis, M;Baltus, B;Koenderman, L
通讯作者: Koenderman, L
DOI: 10.1371/journal.pone.0035513
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Bid HK;Oswald D;Li C;London CA;Lin J;Houghton PJ
通讯作者: Houghton PJ